Mengqi Niu

Chengdu, 610072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A shift toward proteolytic gut fermentation links systemic inflammation to clinical phenotypes in major depressive disorder.

A shift toward proteolytic gut fermentation links systemic inflammation to clinical phenotypes in major depressive disorder.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: April 27, 2026

Selective Anti-Inflammatory Actions of Curcumin on Cytokine Pathways in Major Depressive Disorder.

Selective Anti-Inflammatory Actions of Curcumin on Cytokine Pathways in Major Depressive Disorder.

Journal: Brain and behavior

Published: April 13, 2026

Peripheral metabolic-redox signaling as a core mechanism of major depressive disorder: evidence from deep metabolomic phenotyping.

Peripheral metabolic-redox signaling as a core mechanism of major depressive disorder: evidence from deep metabolomic phenotyping.

Journal: Acta neuropsychiatrica

Published: February 24, 2026

Lower insulin resistance in Chinese patients with severe major depressive disorder: associations with the inflammatory response.

Lower insulin resistance in Chinese patients with severe major depressive disorder: associations with the inflammatory response.

Journal: BMC psychiatry

Published: February 23, 2026

Neurocognitive deficits, psychotrauma, and inflammation shape major depressive disorder and its phenome features.

Neurocognitive deficits, psychotrauma, and inflammation shape major depressive disorder and its phenome features.

Journal: Journal of affective disorders

Published: February 16, 2026

Metabolic hormone and adipokine alterations in major depressive disorder in relation to the acute-phase inflammatory response and early-life adversity.

Metabolic hormone and adipokine alterations in major depressive disorder in relation to the acute-phase inflammatory response and early-life adversity.

Journal: Communications medicine

Published: January 28, 2026

Monomeric CRP and negative acute phase proteins, but not pentameric CRP, as biomarkers of major depression and MDMD.

Monomeric CRP and negative acute phase proteins, but not pentameric CRP, as biomarkers of major depression and MDMD.

Journal: Acta neuropsychiatrica

Published: November 17, 2025

The acute phase inflammatory response as a key determinant of reduced lipid-associated antioxidant defenses in Chinese patients with major depressive disorder.

The acute phase inflammatory response as a key determinant of reduced lipid-associated antioxidant defenses in Chinese patients with major depressive disorder.

Journal: Brain, behavior, and immunity

Published: October 08, 2025

Hypersensitization of peripheral immune cells from major depressive disorder patients is mildly attenuated by fluoxetine in vitro.

Hypersensitization of peripheral immune cells from major depressive disorder patients is mildly attenuated by fluoxetine in vitro.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: August 04, 2025

Decoding Fibromyalgia: Genetic Insights into Gut and Immune System Interactions.

Decoding Fibromyalgia: Genetic Insights into Gut and Immune System Interactions.

Journal: Journal of pain research

Published: March 31, 2025

The immune checkpoint pathophysiology of depression and chronic fatigue syndrome due to preeclampsia: focus on sCD80 and sCTLA-4.

The immune checkpoint pathophysiology of depression and chronic fatigue syndrome due to preeclampsia: focus on sCD80 and sCTLA-4.

Journal: Acta neuropsychiatrica

Published: March 25, 2025

Unraveling the role of gut microbiota and plasma metabolites in fibromyalgia: Insights from Mendelian randomization and dietary interventions.

Unraveling the role of gut microbiota and plasma metabolites in fibromyalgia: Insights from Mendelian randomization and dietary interventions.

Journal: Molecular pain

Published: March 21, 2025

Showing 1-12 of 17

Last Updated: 09/26/2026